CytomX Therapeutics Inc - CTMX - stock price prediction, stock price target, analyst ratings from 7 analysts

CytomX Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of -32.1%, and profit growth estimate of -75.5% for FY25, based on top 7 analyst calls.